Company
About Us
Our Journey
Our Team
Media Kit
Contact
Our Approach
How We Do It
Drug The Undruggable
Partners
Portfolio Companies
Biopharma Partnerships
Research Partnerships
Emerging Biotech Partnerships
AIMS Awards
Pipeline
R&D Pipeline
Co-Developed Pipeline
News & Events
In The News
Press Releases
Blog
Events
Publications
Careers
Careers
Life at Atomwise
Open Positions
Company
About Us
Our Journey
Our Team
Media Kit
Contact
Our Approach
How We Do It
Drug The Undruggable
Partners
Portfolio Companies
Biopharma Partnerships
Research Partnerships
Emerging Biotech Partnerships
AIMS Awards
Pipeline
R&D Pipeline
Co-Developed Pipeline
News & Events
In The News
Press Releases
Blog
Events
Publications
Careers
Careers
Life at Atomwise
Open Positions
Press Releases
Press Releases
Machine Learning-based Virtual Screening and Its Applications to Alzheimer’s Drug Discovery: A Review
Date
September 7, 2018
Tags
AI drug discovery
AI-screening
artificial intelligence
drug discovery
Most Ligand-Based Benchmarks Measure Overfitting Rather than Accuracy
Miro1 Marks Parkinson’s Disease Subset and Miro1 Reducer Rescues Neuron Loss in Parkinson’s Models
